David Larsen
Stock Analyst at BTIG
(1.95)
# 3,150
Out of 5,149 analysts
104
Total ratings
36.05%
Success rate
-6.6%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Reiterates: Buy | $55 | $40.85 | +34.64% | 6 | Mar 2, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $8 | $3.50 | +128.57% | 9 | Feb 25, 2026 | |
| HIMS Hims & Hers Health | Downgrades: Neutral | n/a | $15.94 | - | 4 | Feb 24, 2026 | |
| HQY HealthEquity | Maintains: Buy | $130 → $110 | $80.20 | +37.16% | 6 | Feb 17, 2026 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $37 → $40 | $30.58 | +30.80% | 4 | Feb 17, 2026 | |
| DOCS Doximity | Maintains: Buy | $80 → $50 | $26.79 | +86.64% | 3 | Feb 6, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $10 → $11 | $7.38 | +49.05% | 3 | Feb 2, 2026 | |
| ASTH Astrana Health | Maintains: Buy | $45 → $40 | $24.63 | +62.40% | 3 | Feb 2, 2026 | |
| MDLN Medline | Initiates: Buy | $50 | $43.67 | +14.50% | 1 | Jan 12, 2026 | |
| SLP Simulations Plus | Downgrades: Neutral | n/a | $11.86 | - | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $1.80 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $0.60 | - | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $340 | $185.45 | +83.34% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $2.90 | +244.45% | 4 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.81 | +149.11% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $8.77 | +71.04% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.72 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $17.48 | +60.18% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $174.98 | +48.59% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.10 | +536.36% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.70 | +900.00% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $40.80 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.70 | +47.68% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.20 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $5.18 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $224.00 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $995.80 | -83.93% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $80.21 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $79.80 | +6.52% | 3 | Feb 9, 2018 |
BrightSpring Health Services
Mar 2, 2026
Reiterates: Buy
Price Target: $55
Current: $40.85
Upside: +34.64%
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $10 → $8
Current: $3.50
Upside: +128.57%
Hims & Hers Health
Feb 24, 2026
Downgrades: Neutral
Price Target: n/a
Current: $15.94
Upside: -
HealthEquity
Feb 17, 2026
Maintains: Buy
Price Target: $130 → $110
Current: $80.20
Upside: +37.16%
Consensus Cloud Solutions
Feb 17, 2026
Maintains: Buy
Price Target: $37 → $40
Current: $30.58
Upside: +30.80%
Doximity
Feb 6, 2026
Maintains: Buy
Price Target: $80 → $50
Current: $26.79
Upside: +86.64%
LifeStance Health Group
Feb 2, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $7.38
Upside: +49.05%
Astrana Health
Feb 2, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $24.63
Upside: +62.40%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $50
Current: $43.67
Upside: +14.50%
Simulations Plus
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $11.86
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $1.80
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $0.60
Upside: -
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $185.45
Upside: +83.34%
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.90
Upside: +244.45%
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $2.81
Upside: +149.11%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $8.77
Upside: +71.04%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.72
Upside: -
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $17.48
Upside: +60.18%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $174.98
Upside: +48.59%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $1.10
Upside: +536.36%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.70
Upside: +900.00%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $40.80
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.70
Upside: +47.68%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $5.20
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $5.18
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $224.00
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $995.80
Upside: -83.93%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $80.21
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $79.80
Upside: +6.52%